The end of the line? A case of drug resistance to third-line antiretroviral therapy

Por Rossouw, Theresa M., Hitchcock, Sonia, Botes, Mariëtte
Publicado no South Afr J HIV Med (2016)

Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

Por Eley, Timothy, Huang, Shu-Pang, Conradie, Francesca, Zorrilla, Carmen D., Josipovic, Deirdre, Botes, Mariëtte, Osiyemi, Olayemi, Hardy, Hélène, Bertz, Richard, McGrath, Donnie
Publicado em 2013

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

Por Cooper, David A., Heera, Jayvant, Ive, Prudence, Botes, Mariette, Dejesus, Edwin, Burnside, Robert, Clumeck, Nathan, Walmsley, Sharon, Lazzarin, Adriano, Mukwaya, Geoffrey, Saag, Michael, van Der Ryst, Elna
Publicado em 2014

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Paci...

Por Hamers, Raph L, Oyomopito, Rebecca, Kityo, Cissy, Phanuphak, Praphan, Siwale, Margaret, Sungkanuparph, Somnuek, Conradie, Francesca, Kumarasamy, Nagalingeswaran, Botes, Mariette E, Sirisanthana, Thira, Abdallah, Saade, Li, Patrick C K, Ngorima, Nicoletta, Kantipong, Pacharee, Osibogun, Akin, Lee, Christopher K C, Stevens, Wendy S, Kamarulzaman, Adeeba, Derdelinckx, Inge, Chen, Yi-Ming Arthur, Schuurman, Rob, van Vugt, Michèle, Rinke de Wit, Tobias F
Publicado em 2012